Delivery Order 75N95018G00019-75N95020F00002
Award Date
9/14/20
Potential Completion Date
9/13/22
Potential Value
$1.3M
Federal Agency
National Institute on Drug Abuse
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,672,813.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to SRI International, a non-profit research institute. The contract is for toxicological evaluations of potential medications, which aligns with NIDA's mission of supporting drug abuse and addiction research. SRI International has expertise across biomedical sciences, including preclinical studies and drug...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services, to SRI International, a non-profit research institute. The $3,698,818.25 contract is for non-clinical absorption, distribution, metabolism, and excretion (ADME) studies, with a period of performance from September 19, 2016 to September 18, 2021. This award does not have a small business set-aside. SRI International, as the prime...
This is a $4,228,000.27 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (a component of the U.S. Department of Health and Human Services) to the non-profit research institute SRI International. The contract is for investigational new toxicology studies for drugs to treat Alzheimer's disease and other aging-related diseases. The contract does not have a small business set-aside designation. SRI International is an experienced federal contractor and grantee, frequently...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to SRI International, a large non-profit research and development institute. The contract, valued at $1,726,546.26, is for conducting safety and toxicology studies on cystine, a chemical compound, as part of NIDA's Toxicological Evaluation of Novel Ligands Program. The contract is a cost-plus-fixed-fee type and does not have a small business set-aside....
This is a $1,773,704.00 Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The contract is for a GLP (Good Laboratory Practice) Single Dose Toxicity Study in Dogs, to support the NIDA's Toxicological Evaluations of Potential Medications program. The contract period of performance is from September 13, 2024 to September 12, 2025....
The National Institute of Child Health and Human Development, a civilian federal agency, awarded a $2,369,376 cost-plus-fixed-fee delivery order contract to SRI International, a non-profit research and development organization. The contract is for GLP (Good Laboratory Practice) toxicology, GLP feed, and preclinical studies to support a biological testing facility. This award is part of a larger indefinite delivery vehicle (IDV) contract that enables the agency to efficiently procure SRI's...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
This federal contract award was issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse to SRI International, a non-profit research and development institute, for the Pharmacology and Toxicology for Therapeutics Program (PTTP). The $2,363,694.00 cost-plus-fixed-fee contract is a delivery order under a larger IDIQ (Indefinite Delivery/Indefinite Quantity) vehicle. The contract does not have a set-aside designation. SRI International...
Sri International has been awarded a cost-plus-fixed-fee delivery order valued at $571,190 by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to conduct Task Order 01 for Cocaine Interaction Safety Studies in Rats under the Toxicological Evaluations of Potential Medications IDIQ. The ordering period is from September 12, 2023 through September 11, 2024. The place of performance is West Menlo Park, California. No set-aside designation...